Immune hemolytic anemia and thrombocytopenia secondary to quinidine: in vitro studies of the quinidine-dependent red cell and platelet antibodies.

A patient developed immune hemolysis and thrombocytopenia while receiving quinidine. In vitro testing showed that antiquinidine antibodies of the lgG class were active against both cell lines. Complementand drug-dependent platelet lysis occurred with either the patient’s serum or his lgG fraction; there was no reaction with his 1gM fraction. Drug-dependent red cell antibodies were studied by antiglobulin testing and analysis of the interaction of sensitized red cells with human monocytes in vitro. Antiglobulin testing revealed the presence of cell-adherent lgG. 1gM, and complement; however. lgG-type red cell antibodies were of prime importance in producing red cell ingestion by monocytes. Donor red cells incubated with the drug and the patient’s serum readily adhered to and were ingested by monocytes. The majority of antibody activity was found in the lgG fraction, whereas only a minor degree of phagocytosis was seen with the patient’s 1gM complement fraction. Using the monocyte system. lgG antibodies were detected on the cells, even after extensive washing. This suggests that red cell destruction in this syndrome may occur by a mechanism other than the innocent-bystander type.